|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.2420 - 0.2420|
|52 Week Range||0.0821 - 0.8000|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. The data were presented at the 57th annual meeting of the Society of Thoracic Surgeons.
Last week, you might have seen that Edwards Lifesciences Corporation ( NYSE:EW ) released its annual result to the...